Incidental Unilateral Lateral Cortical Hypertrophy of the Proximal Femur Following Low‐Energy Trauma Without Prior Bisphosphonate Exposure: A Case Report

Read full text Summarise with VIRAT
Authors: Shuichi Miyamoto, Yuichi Yoshii, Toshinori Tsukanishi, Kentaro Mataki, Toru Uchida, Tomohiko Inomoto, Tomoo Ishii
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Prolonged treatment with bisphosphonates has commonly been associated with atypical femur fractures. Localized periosteal thickening of the femoral lateral cortex is considered one of the minor features of these fractures and is caused by distribution of tensile stress and the inhibition of bone resorption. Other medications also potentially influence bone metabolism by inhibiting bone resorption. Here, we present a 60-year-old female with unilateral lateral cortical hypertrophy of the proximal femur with no history of bisphosphonate therapy. Long-term administration of proton pump inhibitors may contribute to cortical hypertrophy in patients with low-bone-turnover osteoporosis attributable to deficiencies in vitamins D and K. Two years after the patient's initial visit to our hospital, radiographs demonstrated a reduction in periosteal thickening along the lateral cortex of the proximal femoral diaphysis. In a bisphosphonate-naive patient with lateral cortical hypertrophy of the proximal femur, proton pump inhibitors' use may represent a contributing factor that warrants consideration due to its potential association with disturbances in bone metabolism.

Fields of Study & Subjects

Bone health and osteoporosis research Bone health and treatments Parathyroid Disorders and Treatments

Publication details

Journal / source
Case Reports in Orthopedics
Volume
2026
Issue
1
Pages
6766372–6766372
Publication date
1 January 2026
Language
EN